| UHC Commercial Medical & Drug | Chemotherapy Observation or Inpatient Hospitalization - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Chromosome Microarray Testing (Non-Oncology Conditions) - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Clinical Trials - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Clotting Factors, Coagulant Blood Products, & Other Hemostatics - Commercial Medical Benefit Drug Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Cochlear Implants - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Cognitive Rehabilitation and Coma Stimulation - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Collagen Crosslinks and Biochemical Markers of Bone Turnover - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Complement Inhibitors - Commercial Medical Benefit Drug Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Continuous Glucose Monitoring and Insulin Delivery for Managing Diabetes - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Cosmetic and Reconstructive Procedures - Commercial and Individual Exchange Medical Policy | 2026-01-01 |